ISG15 and neoplasm: In glioma and anaplastic thyroid carcinoma (ATC), ISG15 inhibits the ubiquitination and degradation of key molecules by ISGylation to activate the expression of downstream stemness genes and enhance tumor stemness characteristics and drug resistance [71, 72].